Nebula Research & Development LLC Purchases Shares of 12,742 CorVel Co. (NASDAQ:CRVL)

Nebula Research & Development LLC bought a new position in shares of CorVel Co. (NASDAQ:CRVL - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 12,742 shares of the business services provider's stock, valued at approximately $1,418,000.

Several other hedge funds have also recently modified their holdings of CRVL. Victory Capital Management Inc. raised its stake in CorVel by 152.8% in the 4th quarter. Victory Capital Management Inc. now owns 109,084 shares of the business services provider's stock valued at $12,137,000 after purchasing an additional 65,940 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of CorVel by 297.2% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,900 shares of the business services provider's stock worth $768,000 after buying an additional 5,163 shares in the last quarter. Steward Partners Investment Advisory LLC raised its position in shares of CorVel by 199.3% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 5,343 shares of the business services provider's stock valued at $594,000 after buying an additional 3,558 shares during the last quarter. American Century Companies Inc. lifted its stake in shares of CorVel by 200.8% in the fourth quarter. American Century Companies Inc. now owns 13,832 shares of the business services provider's stock worth $1,539,000 after buying an additional 9,233 shares in the last quarter. Finally, Federated Hermes Inc. boosted its position in CorVel by 154.9% during the fourth quarter. Federated Hermes Inc. now owns 492 shares of the business services provider's stock worth $55,000 after acquiring an additional 299 shares during the last quarter. Institutional investors and hedge funds own 51.36% of the company's stock.

Analysts Set New Price Targets

Separately, StockNews.com raised CorVel from a "hold" rating to a "buy" rating in a report on Friday, April 18th.

Insiders Place Their Bets

In related news, Director Alan Hoops sold 10,200 shares of CorVel stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $116.39, for a total value of $1,187,178.00. Following the completion of the sale, the director now owns 118,213 shares in the company, valued at approximately $13,758,811.07. This trade represents a 7.94 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Brandon O'brien sold 1,523 shares of the company's stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $119.56, for a total value of $182,089.88. Following the transaction, the chief financial officer now owns 17,142 shares in the company, valued at $2,049,497.52. This trade represents a 8.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,723 shares of company stock valued at $5,757,140 over the last 90 days. 47.57% of the stock is owned by company insiders.

CorVel Trading Up 0.4 %

CRVL stock traded up $0.47 during trading on Thursday, reaching $109.23. 40,316 shares of the stock were exchanged, compared to its average volume of 118,452. The firm has a market capitalization of $5.61 billion, a price-to-earnings ratio of 64.25 and a beta of 0.94. The business has a 50 day moving average price of $110.29 and a 200-day moving average price of $115.66. CorVel Co. has a 1 year low of $76.53 and a 1 year high of $128.61.

CorVel (NASDAQ:CRVL - Get Free Report) last posted its earnings results on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a return on equity of 32.22% and a net margin of 10.12%.

CorVel Profile

CorVel Corporation provides workers' compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.